3 H]5-FU. In addition the LS174T-c2 clone enhanced the cytotoxic effect of 5′-DFUR, but also that of 5-FU, towards co-cultured parental cells. For both anti-cancer agents, this bystander effect did not require cell-cell contact. These results show that both 5-FU or 5′-DFUR could be used together with a TP-suicide vector in cancer gene therapy.
A major drawback of chemotherapy is the lack of specific toxicity towards cancer cells which leads to important side-effects that prevent the treatment from achieving tumour reduction. One strategy that could overcome this problem is to introduce into malignant cells a gene encoding an enzyme that sensitizes them to chemotherapeutic agents. Since the first experiments using the herpes simplex virus thymidine kinase (HSV-TK) (Moolten, 1986; Moolten and Wells, 1990) which activates the acyclic nucleoside analogue ganciclovir (GCV) intratumourally, various drug sensitivity genes ('suicide genes') have been reported (Mullen et al, 1992; Huber et al, 1993; Wei et al, 1994; Parker et al, 1997) .
A critical point of this strategy is the limiting gene transfer efficiency to the tumour mass. However, the ability of a toxic anabolite, metabolically converted in the transfected cells, to diffuse into neighbouring untransfected cells could alleviate the problem. This 'bystander effect' has been observed in many cancer gene therapy experiments, and reduction of tumour mass was observed even when a small percentage of cancer cells were genetically modified (Freeman et al, 1993; . The bystander effect is achieved by diffusion of phosphorylated nucleosides through gap junctions in the HSV-TK/ganciclovir system (Fick et al, 1995) . However, experiments with other suicide genes, such as cytosine deaminase which cleaves 5-fluorocytosine to 5-fluorouracil (5-FU), have shown the advantages of a diffusible, gap junctionindependent bystander effect (Huber et al, 1994; Trinh et al, 1995; Denning and Pitts, 1997) .
Thymidine phosphorylase (EC 2.4.2.4) (TP), also described as the angiogenic platelet-derived endothelial cell growth factor (PD-ECGF) (Ishikawa et al, 1989; Moghaddam and Bicknell, 1992; Sumizawa et al, 1993; Miyadera et al, 1995) , is a homodimeric enzyme with a monomeric molecular mass of about 55 kDa (Desgranges et al, 1981; Miyazono et al, 1987) and which phosphorolytically cleaves thymidine to yield thymine and deoxyribose 1-phosphate (Friedkin and Roberts, 1953; Krenitsky, 1968) . TP is expressed in various human cells and tissues and plays a role in plasma thymidine homeostasis (Zimmerman and Seidenberg, 1964; Shaw et al, 1988; Fox et al, 1995) . The levels of expression in different human tissues can vary up to 15-fold (Yoshimura et al, 1990) . Moreover, TP levels are increased in several types of malignant tumours when compared to the non-neoplastic regions of these tissues (Obrien et al, 1996) , and also in the plasma from tumour-bearing animals and cancer patients (Luccioni et al, 1994) .
TP is also a key enzyme in the metabolic activation of fluoropyrimidines that share the physiological pathway of pyrimidines. TP is responsible for the conversion of 5′-deoxy-5-fluorouridine (5′-DFUR, doxifluridine) to 5-FU and, because of its reversible phosphorolytic activity, assumes also the conversion of 5-FU to its anabolite 5-fluoro-2′-deoxyuridine (5-FdUrd). Transfection experiments have provided evidence that TP mediates the sensitivity of HT-29 human colon carcinoma cells to 5-FU (Schwartz et al, 1995) , and of MCF-7 human breast cancer cells to 5′-DFUR (Patterson et al, 1995) . Furthermore, the induction of TP expression by interferon increases 5-FU cytotoxicity (Schwartz et al, 1994 (Schwartz et al, , 1998 Summary 5-Fluorouracil (5-FU) and 5′-deoxy-5-fluorouridine (5′-DFUR), a prodrug of 5-FU, are anticancer agents activated by thymidine phosphorylase (TP). Transfecting the human TP cDNA into cancer cells in order to sensitize them to these pyrimidine antimetabolites may be an important approach in human cancer gene therapy research. In this study, an expression vector containing the human TP cDNA (pcTP5) was transfected into LS174T human colon carcinoma cells. Eight stable transfectants were randomly selected and analysed. The cytotoxic effects of 5-FU and 5′-DFUR were higher in TP-transfected cells as compared to wild-type cells. The maximal decreases in the IC 50 were 80-fold for 5-FU and 40-fold for 5′-DFUR. The increase in sensitivity to these pyrimidines of TP-transfected cells significantly correlated with the increase in both TP activity and TP expression. Transfected clone LS174T-c2 but not wild-type cells exhibited formation of [ could be a prognostic marker for the 5-FU cytotoxicity in vitro and in vivo (Fox et al, 1997; Griffiths and Stratford, 1997; Mader et al, 1997) . In a recent paper, we have demonstrated an increased 5-FU sensitivity of a murine adenocarcinoma cell line in vitro and in vivo after transfection of TP cDNA (Evrard et al, 1999) . Therefore, TP gene transfer in cancer cells in order to enhance their sensitivity to fluoropyrimidines could be a promising strategy in cancer gene therapy.
In this report, we investigated the effect of TP overexpression in human LS174T colorectal cancer cells on [ 3 H]5-FU metabolism and on 5-FU and 5′-DFUR sensitivity. We next examined the bystander effect on neighbouring untransfected cells in contact and non-contact conditions. 
MATERIALS AND METHODS

Chemicals
Cell lines
The human colorectal adenocarcinoma LS174T cells (ATCC number, CL-188) were cultured at 37°C in a fully humidified 5% carbon dioxide atmosphere in RPMI-1640 medium supplemented with 10% fetal calf serum (FCS) and 2 mM glutamine. COS-7 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 5% FCS and 2 mM glutamine.
Human TP cDNA subcloning
The TP cDNA was kindly provided by Dr Rangana Choudhuri (Imperial Cancer Research Fund, University of Oxford, UK). The full-length human TP cDNA was obtained by digesting the parental pPL5 vector with XbaI and HindIII and the insert was ligated into the same sites of the mammalian expression vector pcDNA3 (Invitrogen, NV Leek, The Netherlands) to produce pcTP5. This vector was then transformed into cells (Escherichia coli, DH5α) and the plasmid DNA purified using a Qiagen Plasmid Kit (Qiagen, Courtaboeuf, France).
Transfection of human TP cDNA in COS-7 cells and LS174T cells
COS-7 and LS174T cells (1 × 10 6 per 20 cm 2 Petri dish) were cultured for 24 h until cells were approximately 80% confluent. They were then transfected with pcTP5 or pcDNA3 (control) using the Lipofectamine™ reagent (Life Technologies, Cergy-Pontoise, France) using conditions as recommended by the manufacturer. After 48 h incubation, COS-7 cells were lysed and assayed for TP activity and expression. Stable LS174T/pcTP5 transfectants were selected for geneticin (G418 sulphate, Life Technologies, Cergy-Pontoise, France) resistance (250 µg ml -1 culture medium), and eight clones were randomly selected and analysed for 5-FU and 5′-DFUR sensitivity, TP activity and protein expression.
Cell lysis
Cells (COS-7 or LS174T) were homogeneized on ice in 100 µl of a lysis buffer containing 50 mM Tris-HCl (pH 8.0), 150 mM sodium chloride, 100 µg ml -1 phenylmethylsulphonyl fluoride (PMSF), 1 µg ml -1 aprotinin and 1% Triton X-100. The lysates were centrifuged at 20 000 g for 30 min at 4°C and protein level of the supernatants was determined according to Bradford (1976) .
Immunoblotting and immunocytostaining
The mouse monoclonal IgG1 654-1 raised against human TP was kindly provided by Nippon Roche Research Center (Nishida et al, 1996) and was used as primary antibody for either immunoblotting or immunocytostaining experiments. For immunoblotting, supernatant proteins (20 µg) of cell lysates, obtained as described above, were separated on sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). The proteins were electroblotted onto nitrocellulose membrane, and incubated with 0.2 µg ml -1 of primary antibody followed by horseradish peroxidase-conjugated goat anti-mouse IgG (Sigma, St Quentin Fallavier, France). Immunolabelled proteins were vizualized using X-ray film after incubation with ECL reagents. For immunocytostaining, cells were seeded on cover-slips in 12-well plates. After fixing with methanol and permeabilization with phosphate-buffered saline (PBS)-0.1% Triton, cells were incubated with 1 µg ml -1 of primary antibody followed by fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG (Sigma, St Quentin Fallavier, France).
TP activity assay
The enzyme activity in cell lysates was assayed as previously described (Yoshimura et al, 1990) , with minor modifications. Briefly, 50 µl of supernatants were added to 150 µl of a reaction mixture consisting of 10 mM thymidine, 10 mM KH 2 PO 4 (pH 8.4) and then incubated at 37°C for 4 h. The reaction was stopped by the addition of 800 µl of 0.2 N sodium hydroxide. The absorbance at 300 nm was determined and the amount of thymine in the reaction mixture was calculated using a calibration curve. The TP activity was expressed as pmol thymine
[
H]5-FU metabolism analysis
Cells (2 × 10 6 ) were seeded in a 25 cm 2 flask and were treated for 4 h with 100 µCi of [ 3 H]5-FU (corresponding to a final concentration of 1.6 µM). Cells were then harvested and vortexed in 60% methanol. After methanol evaporation, the mobile phase (100 µl) was added to the residue for HPLC injection. Chromatographic conditions were as follows: reverse phase column, Licrosphere C8, 5 µm; mobile phase, buffer pH 7 10% (1.7 mM K 2 HPO 4 , 5 mM tetrabutylammonium nitrate): methanol 90%; flow rate 1 ml min -1 ; isocratic conditions. Detection was performed using a radiometric detector (Flo-One Beta Radiomatic, Packard Instrument SA) and peaks identified by comparing retention times with standards.
In vitro cytotoxicity assay
The effect of anticancer agents (5-FU, 5′-DFUR) on cell viability was assessed using the neutral red assay as previously described (Evrard et al, 1996) . Briefly, aliquots of cell suspension (5 × 10 3 cells per well) were seeded in 96-well microtitre plates which were incu-bated for 24 h at 37°C in a fully humidified atmosphere of 5% carbon dioxide in air. The cells were then incubated for 72 h in the absence (control) or the presence of different drug concentrations (150 µl in fresh medium per well, eight wells per agent concentration). Thereafter, cells were washed with PBS and 150 µl of a neutral red solution (40 µg ml -1 ) was added. After 3 h at 37°C, 5% carbon dioxide, the cells were washed with PBS and destained with 150 µl of glacial acetic acid (1%)-ethanol (50%) (v/v). Absorbances at 540 nm (A 540 ) were measured using a microplate reader (Labsystems Multiscan MS). The effect of the drugs on cell survival was expressed as a growth ratio calculated using the equation A 540 drug-treated/A 540 control.
Assessment of in vitro bystander effect
TP-transfected LS174T-c2 cells and parental cells were mixed in various ratios [c2 cells/(c2 cells + parental cells)] and seeded 5 × 10 3 cells ml -1 in 96-well plates. After 24 h at 37°C, the cells were incubated for 3 days in the absence (control) or the presence of different drug concentrations (0.01-100 µM) and the neutral red uptake assay was performed as described above. The results are expressed as a growth ratio relative to drug-free controls. To study the requirement of direct cell-cell contact for the bystander effect, parental LS174T cells were seeded in the bottom chamber of 96-well microtitre plates (5 × 10 3 cells per well) and parental or LS174T-c2 cells (5 × 10 3 cells per insert) were placed in the top chamber of membrane culture inserts (Anopore membrane, pore size 0.02 µM, Nunc, France). After a 24 h incubation at 37°C, cells were treated for 72 h with different concentrations of 5-FU or 5′-DFUR (0.1-100 µM) which were added into the membrane culture inserts. Thereafter, the membrane culture inserts were removed and the survival of parental cells seeded in the microtitre plates was measured as described above.
RESULTS
Subcloning of the human TP cDNA
In order to transfect the human TP cDNA in mammalian tumour cells, we subcloned the full-length cDNA in the mammalian expression vector pcDNA3 in a sense orientation with respect to the CMV promoter. The functionality of pcTP5 was assessed by studying the protein expression and the enzyme activity in lysates from COS-7 cells transfected with the plasmid. As shown in Figure 1 , a strong and specific production of immunodetectable human TP and a high TP activity were evident in pcTP5-transfected cell lysates. An endogeneous TP activity was found in wildtype COS-7 cells but the protein was not detected because the anti-TP antibody is specific for human and not simian TP.
Expression of human TP in LS174T cells
Human adenocarcinoma LS174T cells were transfected with the pcTP5 and stable transfectants were selected for geneticin resistance.
The growth rate of the transfected LS174T cells did not significantly vary from that of the wild-type cells or that of pcDNA3-transfected cells (data not shown). Eight clones of pcTP5-transfected cells (c1 to c8) were randomly selected and analysed for TP activity and expression. The levels of enzyme activity, ranging from 0 to 730 pmol
, were closely related to protein expression as shown by Western blot experiments (Figure 1) . The parental cells expressed neither immunodetectable TP nor significant TP activity. Clone 2 (LS174T-c2), which exhibited the highest TP protein expression and activity (Figures 1 and 2) , was used for analysis of the bystander effect and [ 
In vitro cytotoxicity
The effect of human TP expression on the sensitivity of LS174T cells to 5-FU and 5′-DFUR was studied by using the neutral red uptake assay. 5-FU and 5′-DFUR decreased the cell viability in a concentration-dependent fashion. The results expressed as IC 50 are shown in Table 1 . The sensitivity to the fluoropyrimidines of LS174T cells transfected with pcDNA3 was not significantly different from that of parental cells. On the other hand, TPexpressing LS174T cells were more sensitive to the cytotoxic actions of 5-FU and 5′-DFUR than the parental cells. Clones 2 and 
Bystander effect
Mixed cultures of parental and TP-transfected cells were generated to study the involvement of a bystander effect in the in vitro cytotoxicity of 5-FU and 5′-DFUR. When parental LS174T cells were co-cultured with LS174T-c2 cells at a ratio of 0.1, the IC 50 values of 5-FU and 5′-DFUR were lowered approximately tenfold, indicating a clear bystander effect (Figure 5 A, B ). There were significant bystander effects (50% cell death) for both anticancer agents (5 µM final concentration) even when only 5% of cells were transfected (Figure 5 C, D) .
We next investigated whether this bystander effect would require direct cell-cell contact. The sensitivity to 5-FU of parental cells was significantly higher when they were co-cultured, as described above, with LS174T-c2 cells rather than with parental cells in the culture inserts ( Figure 6A ). Similar results were obtained with 5′-DFUR ( Figure 6B) . (Cohen et al, 1993) . Different strategies, including combination of 5-FU with other cytotoxic agents or with cytokines, are invoked to increase the sensitivity of cancer cells to fluoropyrimidines (Elias and Crismann, 1988; Schwartz et al, 1994) . A new gene transfer approach is based on the fact that 5-FU and 5′-DFUR, a prodrug of 5-FU, are activated by TP. Thus, transferring the gene encoding human TP into cancer cells could render them more susceptible to 5-FU and/or 5′-DFUR. In this report, we examined the effects of TP gene transfer in human colon cancer cells LS174T and their subsequent sensitivity to fluoropyrimidines. The human colon adenocarcinoma cell line LS174T was chosen for establishing stable transfectants. Neither TP activity nor TP expression were detectable in parental LS174T cells. Therefore, LS174T cell line was an ideal model for studying the effects of TP overexpression on colonic cancer cells sensitivity to fluoropyrimidines. From the selected TP-transfected cell clones, we observed a good correlation between protein expression and TP activity levels. Clone LS174T-c2, which exhibited the highest TP activity, was chosen for [ 3 H]5-FU metabolic profile analysis and bystander effect experiments.
5-FU has been reported to be activated through two distinct pathways (Rustum et al, 1997; Sobrero et al, 1997) . The first anabolite after 5-FU activation by TP, i.e. [ 3 H]FdUrd, was not detected in transfected cells, suggesting that the conversion of FdUrd to FdUMP by thymidine kinase is not a limiting step and occurs rapidly. This result, as previously suggested (Mader et al, 1997) , argues against a decisive role of thymidine kinase in the activation of 5-FU. In conclusion, these data clearly indicate that TP is able to activate 5-FU when overexpressed in LS174T cancer cells.
We next assessed the in vitro sensitivity to 5-FU and 5′-DFUR of parental and TP-transfected LS174T cells. The cytotoxicity of both 5-FU and 5′-DFUR was enhanced by TP expression; cell sensitivity and TP activity were correlated highly. The maximal decreases in the IC 50 values observed with LS174T-c2 cells were 80-fold for 5-FU and 40-fold for 5′-DFUR. Such a significant increase of both fluoropyrimidines cytotoxic effects by TP gene transfer into human cancer cells has never been reported so far. Schwartz et al (1995) reported a lower enhancement (19-fold) of human colon cancer cells (HT-29) sensitivity to 5-FU by TP transfection. Other works have shown that TP transfection in MCF-7 (Patterson et al, 1995) or PC-9 (Kato et al, 1997) cells increased the sensitivity to 5′-DFUR but not to 5-FU. This discrepancy could be explained by a higher sensitivity of the parental cells to 5-FU correlated to an endogenous TP activity. Therefore, parental LS174T cells which exhibit no TP activity were relatively resistant to 5-FU despite activation of 5-FU by UP. Activation of the desoxyribonucleotides pathway by TP overexpression in LS174T cells greatly enhanced 5-FU cytotoxicity. Our data are consistent with previous reports proposing TP as a biochemical determinant of response to 5-FU and suggest that the loss of TP activity could be responsible for 5-FU resistance (Chu et al, 1990; Schwartz et al, 1995; Fox et al, 1997; Mader et al, 1997) .
By contrast, parental LS174T displayed high sensitivity to 5′-DFUR when compared to PC-9 (Kato et al, 1997) or KB cancer cell lines. Since LS174T cells express significant UP activity but no TP activity, 5′-DFUR may be efficiently activated by the endogeneous UP. After TP transfection, LS174T-c2 clones were found to be 40-fold more sensitive to 5′-DFUR than parental cells. This result strongly suggests that metabolic activation of 5′-DFUR is achieved by both TP and UP in cancer cells. Therefore, a cancer gene therapy approach using 5′-DFUR as prodrug and TP as a suicide gene should account for basal TP activity and also basal UP activity of tumour cells.
The increased sensitivity to 5-FU and 5′-DFUR of TP transfected LS174T cells has led us to examine the neighbouring cytotoxicity on adjacent, untransfected cells. In agreement with previous reports (Patterson et al, 1995; Kato et al, 1997) , we describe here a bystander effect with 5′-DFUR and, moreover, we demonstrate for the first time a bystander effect with 5-FU. In our experiments, a TP-transfected cell ratio of 0.05 is sufficient to obtain 50% cell death and a ratio of 0.2-0.3 is sufficent for a maximal effect on the whole cell population in the presence of 5 µM 5-FU or 5′-DFUR.
Depending on the suicide gene, the bystander effect can be achieved by diffusion of activated anabolites from transfected to untransfected cells in a cell-cell contact-dependent (Fick et al, 1995) or -independent (Huber et al, 1994; Chen and Waxman, 1995; Kato et al, 1997) is able to cross the cell membrane through an in-and-out nucleoside transport (Grem and Fisher, 1986; Lonn et al, 1989) we suggest that 5-FdUrd, although not detected in HPLC experiments, could be responsible for the diffusible bystander effect observed in cytotoxicity assays in non-contact conditions. We are aware of the angiogenic effect of TP and of the potential resulting tumour growth enhancement. However, we think that it does not compromise its use as a suicide gene because TP-transfected cells would not be able to promote angiogenesis in so far as they would be selectively killed by the fluoropyrimidine chemotherapy. On the other hand, a transient expression of TP in target cells could overcome this problem.
In conclusion, our data suggest that level of TP activity is strongly implicated in the 5′-DFUR but also 5-FU sensitivity of human colon carcinoma cells. Therefore TP should be considered as a potential suicide gene for cancer gene therapy with 5-FU or 5′-DFUR. High gene transfer efficiency and specific targeting of TP gene in tumour cells could be achieved by using recombinant viral vectors and promoter elements of genes usually transcribed by tumours such as carcinoembryonic antigen in colon carcinoma. Furthermore, our results have a direct clinical relevance, especially since a number of 5-FU prodrugs such as capecitabine, activated by TP, are in clinical trials. Thus, these data should provide a basis for measuring TP in clinical material and correlate with outcome of fluoropyrimidine-based therapy.
